SiO2 Medical Products announced a strategic investment by Novartis to explore and potentially use its materials sciences for packaging technology in a range of products. Investment confirms interest ...
SiO2 Medical Products, Inc. (SMP) is a U.S. based, privately-held company founded in 2011. SMP has successfully developed and commercialized a wide range of novel products for use in pharmaceutical ...
Investment confirms interest to use SiO2's technology that may provide advantages including enhanced quality and performance SiO2's breakthrough technology is anticipated to help provide regulatory ...
AUBURN, Ala., Nov. 18, 2019 /PRNewswire/ -- SiO2 Medical Products today announced a strategic investment by Novartis to explore and potentially use its materials sciences for packaging technology in a ...
Enhanced packaging (low particulates, Silicone oil and Tungsten-free, no delamination, glass-like oxygen barrier, tighter dimensional control, no breakage); Innovative materials science technology to ...
AUBURN, Alabama, Nov. 18, 2019 /PRNewswire/ -- SiO2 Medical Products today announced a strategic investment by Novartis to explore and potentially use its materials sciences for packaging technology ...
Investment confirms interest to use SiO2's technology that may provide advantages including enhanced quality and performance AUBURN, Alabama, Nov. 18, 2019 /PRNewswire/ -- SiO2 Medical Products today ...
*投資により、品質とパフォーマンスの向上などのメリットをもたらす可能性のあるSiO2の技術を使用する利益を確保 *SiO2の画期的技術は、規制上のメリット、一次パッケージングの改善、および様々な製品の潜在的な運営コストの削減に役立つと予想 ...
SiO2 Medical Products today announced a strategic investment by Novartis to explore and potentially use its materials sciences for packaging technology in a range of products. SiO2's containers are ...
AUBURN, Ala., Aug. 1, 2017 /PRNewswire/ -- SiO 2 Medical Products, Inc. ("SMP"), a U.S.-based designer, developer, manufacturer, and supplier of pharmaceutical ...
Pharmaceutical and biological customers can benefit from an extended supplier offering for their fill-finish lines and from a faster drug product time-to-market The agreement will enable ...
Pharmaceutical and biological customers can benefit from an extended supplier offering for their fill-finish lines and from a faster drug product time-to-market PADUA, Italy and AUBURN, Alabama, Feb.
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する